Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64.3M
-
Number of holders
-
156
-
Total 13F shares, excl. options
-
51.3M
-
Shares change
-
+9.42M
-
Total reported value, excl. options
-
$2.21B
-
Value change
-
+$452M
-
Put/Call ratio
-
2.37
-
Number of buys
-
118
-
Number of sells
-
-37
-
Price
-
$43.12
Significant Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q1 2024
172 filings reported holding VERA - Vera Therapeutics, Inc. - COMMON STOCK as of Q1 2024.
Vera Therapeutics, Inc. - COMMON STOCK (VERA) has 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.3M shares
of 64.3M outstanding shares and own 79.74% of the company stock.
Largest 10 shareholders include Avoro Capital Advisors LLC (5.27M shares), BlackRock Inc. (3.32M shares), COMMODORE CAPITAL LP (3.17M shares), FMR LLC (3.12M shares), Sofinnova Investments, Inc. (2.79M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.39M shares), STATE STREET CORP (2.35M shares), VANGUARD GROUP INC (2.15M shares), Eversept Partners, LP (1.82M shares), and MORGAN STANLEY (1.54M shares).
This table shows the top 156 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.